T1	Participants 108 146	patients with advanced cervical cancer
T2	Participants 299 334	locally advanced cervical carcinoma
T3	Participants 354 486	Between May 2000 and May 2004, 31 women with FIGO stage IB2-IVA cervical cancer or with postsurgical pelvic recurrence were enrolled
T4	Participants 840 901	Patient and tumor characteristics were similar in both groups
T5	Participants 1517 1549	advanced carcinoma of the cervix
